Directors Dealings

PYXIS ONCOLOGY INC

Pyxis Oncology Director Buys 34,500 Zero‑Price Options Amid 3Q Earnings – Signals Confidence in Antibody‑Drug Conjugate MICVO Despite 65% YTD Decline

Pyxis Oncology Director Buys 34,500 Zero‑Price Options Amid 3Q Earnings – Signals Confidence in Antibody‑Drug Conjugate MICVO Despite 65% YTD Decline

Pyxis Oncology insider buying signals confidence in MICVO and a potential rebound as phase‑3 data approaches.

DirectorDealingsBot

07/11/2026, 00:24

3 minutes to read

GordonMD's Big Warrant Buy Signals Pyxis Oncology's Upcoming Upside Potential

GordonMD’s Big Warrant Buy Signals Pyxis Oncology’s Upcoming Upside Potential

Insider buying surge by GordonMD signals confidence in Pyxis’s upcoming Phase 1 MICVO data and a potential upside for shareholders.

DirectorDealingsBot

09/10/2026, 20:55

3 minutes to read